Further investigations highlighted distinctive variations in the abundance of the third and fourth repeats in the microtubule-binding region (MTBR) of tau in AD compared to FTLD, suggesting AD-specific tau abnormalities beyond phosphorylation and their potential as biomarkers differentiating AD from primary tauopathies [29]. Here, MAPT is linked to Alzheimer disease.